Barinthus Biotherapeutics plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BRNS Nasdaq 2836 www.barinthusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Barinthus Biotherapeutics plc

Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments - Apr 30th, 2026 5:30 am
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments - Mar 13th, 2026 6:00 am
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock? - Dec 15th, 2025 10:00 am
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Dec 10th, 2025 6:00 am
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments - Nov 7th, 2025 5:30 am
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics - Oct 24th, 2025 9:00 am
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases - Sep 30th, 2025 7:56 am
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments - Aug 7th, 2025 6:00 am
Broadwind Leads The Charge With 2 Other Prominent Penny Stocks - Jul 17th, 2025 12:05 pm
Q2 Virtual Investor Summit: Presentations Available Now - Jun 25th, 2025 9:15 am
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025 - Jun 9th, 2025 7:00 am
Metalpha Technology Holding And 2 Other Promising Penny Stocks - Jun 2nd, 2025 12:05 pm